Historical perspective of the renin-angiotensin system

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 24, Issue 1, 2003, Pages 27-39

  Hall, John E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Hypertension; Kidney; Sodium excretion

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; RENIN;

ALDOSTERONE RELEASE; ANIMAL MODEL; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; HEART FAILURE; HISTORY OF MEDICINE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MACULA DENSA; NONHUMAN; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM ABSORPTION; SODIUM EXCRETION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINS; ANIMALS; BLOOD PRESSURE; HEMOSTASIS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; HYPERTENSION; RENIN-ANGIOTENSIN SYSTEM;

ANIMALIA; GLOMERULUS;

EID: 0037952930     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:24:1:27     Document Type: Review

References (70)

1. Aurell, M. (1998) The renin-angiotensin system - The centenary jubilee. Blood Pressure, 7, 71-75.
2. Page, I. H. (1987) Hypertension Mechanisms. Grune & Stratton, Orlando, FL.
3. Robertson, J. I. S. (1993) Renin and angiotensin: an historical review, in The Renin-Angiotensin System (Robertson, J. I. S. and Nicholls, M. G., eds.) Gower, London, pp. 1-18.
4. Aurell, M. (1998) Robert Tigerstedt - scientist, teacher and critic, in Renin-Angiotensin (Ulfendahl, H. R. and Aurell. M., eds.) Portland Press, London, pp. 1-12.
5. Skeggs, L. (1986) Current concepts and historical perspectives of renal pressor mechanisms. J. Hypertension, 4, (suppl. 4): S3-S10.
6. Pickering, G. W. (1982) Systemic arterial hypertension., in Circulation of the Blood - Men and Ideas. (Fishman, A.P. and Richards, D.W., eds.) The American Physiological Society, Waverly Press Inc., Baltimore, pp. 487-541.
7. Inagami, T. (1998) A memorial to Robert Tigersteadt - The centennial of renin discovery. Hypertension, 32, 953-957.
8. Tigerstedt, R. and Bergman, P. G. (1898) Niere und kreislauf. Skand. Arch. Physiol. 8, 223-271.
9. Janeway, T.C. (1909) Note on the blood pressure changes following reduction of the renal arterial circulation. Proc. Soc. Exp. Biol. Med., 109, 5-6.
10. Goldblatt, H., et al. (1934) Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med., 59, 347-380.
11. Harrison, T. R., Blalock A., and Mason, M. F. (1937) Effect on blood pressure of injection of kidney extracts of dogs with renal hypertension. Proc. Soc. Exp. Biol., 35, 38.
12. Prinzmetal, M. and Friedman, B. (1937) Pressor effects of kidney extracts from patients and dogs with hypertension. Proc. Soc. Exp. Biol., 35, 122.
13. Fasciolo, J.C., et al. (1938) The blood pressure raising secretion of the ischemic kidney. J. Physiol. 94, 281-290.
14. Houssay, B. A. and Taquini, A. C. (1938) Acción Vasoconstrictora de la sangre venosa del riñon isquemiado. Rev. Soc. Argent. Bio. 14, 5.
15. Kohlstaedt, K.G., Helmer, O., and Page, I.H.(1938) Activation of renin by blood colloids. Proc. Soc. Exp. Biol. Med., 39, 214-215.
16. Muá-áoz, J.M., et al. (1939) Hypertensin: the substance causing renal hypertension. Nature, 144, 980.
17. Page I. H., and Helmer, O.H. (1940) A crystalline pressor substance (angiotonin) resulting from the interaction between renin and renin-activator. J. Exp. Med., 71, 29-42.
18. Braun-Menéndez, E., et al. (1940) The substance causing renal hypertension. J. Physiol. 98, 283-298.
19. Braun-Menéndez, E., Page I. H. (1958) Suggested revision of nomenclature - angiotensin. Science NE, 127, 242.
20. Skeggs. L. T., Marsh, W. H., Kahn, J. R., and Shumway, N. P. (1954) The purification of hypertension I. J. Exp. Med., 100, 363.
21. Skeggs, L. T., Marsh, W. H., Kahn, J. R., and Shumway, N. P. (1954) The existence of two forms of hypertensin. J. Exp. Med. 29, 275.
22. Skeggs, L. T., et al. (1956) Preparation and function of the hypertensin-converting enzyme. J. Exp. Med. 103, 295-305.
23. Skeggs, L. T., Lentz, K. E., Kahn, J. R., Shumway, N. P., Woods, K. R. (1956) The amino acid sequence of hypertensin II. J. Exp. Med. 104, 193-197.
24. Elliott, D. F. and Peart, W. S. (1956) Amino acid sequence in a hypertensin. Nature 177, 527-528.
25. Skeggs, L.T., Kahn, J. R., Lentz, K. E., and Shumway, N. T. (1957) The preparation, purification, and amino acid sequence of a polypeptide renin substrate. J. Exp. Med. 106, 439-453.
26. Bumpus, F. M. Schwarz, H., and Page, I. H. (1957) Synthesis and pharmacology of the octapeptide angiotonin. Science 125, 3253.
27. Rittel, W. B., Iselin, B., Kappeler, H., Riniker, B., and Schwyzer, R. (1957) Synthese eines hochwirksamen hypertensin II-amids (L-asparagynl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L- histidyl-L-prolyl-L-phenylalanin). Helv. Chim. Acta., 40, 614-624.
28. Gross, R. (1958) Renin und Hypertensin: Physiologische oder pathologische Wirkstroffe? Klinische Wochenschrift 36, 693-706.
29. Davis, J. O. (1959) Discussion. Recent Progress in Hormone Research. 15, 298-303.
30. Laragh, H. H., Angers, M., Kelly, W. G., and Lieberman, S. (1960) Hypotensive agents and pressor substances: The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man. JAMA 174, 240-243.
31. Genest, J., Nowaczynski, W., Noiw, E. Sandor, T., and Biron, P. (1960) Adrenocortical function in essential hypertension. In Essential Hypertension (Bock, K. D., and Cottier, P. T., eds.) Springer-Verlag, Berlin. pp. 126-146.
32. Mulrow, P. J. and Ganong, W. R. (1961) Stimulation of aldosterone secretion by angiotensin II. Yale J. Biol. Med. 33, 386-395.
33. Simpson, S. A. S. and Tait J.F. (1953) Physiochemical methods of detection of a previously unidentified adrenal hormone. Mem. Soc. Endocrinol. 2, 9-24.
34. Merrill, A., Williams, R. H., and Harrison, TR. (1938) The effects of a pressor substance obtained from the kidneys on the renal circulation of rats and dogs. Am. J. Med., 96, 240-246.
35. Corcoran, A. C. and Page, I. H. (1940) The effects of angiotensin on renal blood flow and glomerular filtration. Am. J. Physiol. 130, 335-339.
36. Goormaghtigh N. (1937) L'Appareil neuromyart(riel juxtaglom(rulaire du rein: ses reactions en pathologie et ses rapports avec le tube urinef(re. C. R. Soc. Biol. (Paris), 124, 293-296.
37. Guyton, A. C. (1963) Theory for autoregulation of glomerular filtration rate and blood flow in each nephron by the juxtaglomerular apparatus. The Physiologist, 6, 194.
38. Thurau, K. (1964) Renal hemodynamics. Am. J. Med.,36: 698-719.
39. Vander, A and Miller, R. (1964) Control of renin secretion in the anesthetized dog. Am. J. Physiol. 207, 537-546.
40. Hall, J.E., Guyton, A. C., Jackson, T. E., Coleman, T. G., Lohmeier, T. E., and Trippodo, N. C. (1977) Control of glomerular filtration rate by renin-angiotensin system. Am. J. Physiol., 233, F366-F372.
41. Anderson S, Rennke H. G., and Brenner, B. M. (1986) Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J. Clin. Invest. 77, 77:1993-2000.
42. Ames, R. P., Borkowski, A. J., Sicinski, A., and Laragh, J. H. (1965) Prolonged infusions of angiotensin II and norepinephrine and blood pressure, electrolyte balance, and aldosterone and cortisol secretion in normal man and in cirrhosis with ascites. J. Clin. Invest. 44, 1171-1185.
43. Freeman, R. H., Davis, J. O., Vitale, S. J., and Johnson, J. A. (1973) Intrarenal role of ang2iotensin II. homeostatic regulation of renal blood flow. Circ. Res., 32, 692-698.
44. Hall, J. E., Guyton, A. C., Trippodo, N. C., Lohmeier, T. E., McCaa, R. E., and Cowley, A. W., Jr. (1977) Intrarenal control of electrolyte excretion by angiotensin II. Am. J. Physiol. 233, F538-F544.
45. Kimbrough, H. M., Jr., Vaughn, E. D., Jr, Carey, R.M., and Ayers, C. R. (1977) Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ. Res, 40, 174-178.
46. Hall, J. E., Guyton, A. C., Smith, M. J., Jr., and Coleman, T. G. (1980) Blood pressure and renal function during chronic changes in sodium intake: role of angiotensin. Am. J. Physiol., 239, F271-F280.
47. Harris, P. J. and Young, J. A. (1977) Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney. Pflugers Arch., 367, 295-297.
48. Schuster, V. L., Kokko, J. P., Jacobson, H. R. (1984) Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J. Clin. Invest. 73, 507-515.
49. Guyton, A. C., and Coleman, T. G. (1969) Quantitative analysis of the pathophysiology of hypertension. Circ. Res., 24(Suppl I), 1-19.
50. Starling, E. H. (1909) The fluids of the body, in The Herter Lectures, Keever, Chicago.
51. Goll, R. (1854) Uber den Einfluss des Blutdrucks auf die Harnabsonderung. Z. Natural. Med. 4, 78.
52. Selkurt, E. E., Hall, P. W., and Spencer, M. P. (1949) Effect of graded arterial pressure decrement on renal clearance of creatinine, P-amino hippurate and sodium. Am. J. Physiol. 159, 369-384.
53. Haber, E., Koemer, T. Page, L. B., Kliman, B., and Purnode, A. (1969) Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J. Clin. Endocrinol. Metab. 29, 1349-1355.
54. Boyd, G. W., Adamson, A. R., Fitz, A. E., and Peart, W.S. (1969) Radio-immunoassay determination of plasma-renin activity. Lancet 1, 213-218.
55. Khairallah, P. A., Toth, A., and Bumpus, F. M. (1970) Analogs of angiotensin II. Mechanism of receptor interactions. J. Med. Chem. 13, 181.
56. Pals, D. T., Masucci, F.D., Sipos, F., and Denning, G. S. (1971) Specific competitive antagonists of the vascular action of angiotensin II. Circ. Res. 29, 664-672.
57. 8-angiotensin II for understanding and treatment of high blood-pressure. Lancet 1, 1945-1948.
58. Gavras, H., Brunner, H. R., Vaughn E. D., Jr., and Laragh, J. H. (1973) Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats. Science 180, 1369-1372.
59. Ferreira, S. H. and Rocha e Silva, M. (1965) Potentiation of bradykinin and eledoisin by BPF (bradykinin-potentiating factor) from Bothrops jararaca venom. Experientia 21, 347-349.
60. Bahkle, Y. S. (1968) Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung. Nature 220, 919-921.
61. Ondetti, M.A., Williams, N.J. Sabo, E.F., Pluscec, J., Weaver, E.R., and Kocy, O. (1971) Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure and synthesis. Biochemistry 10, 4033-4039.
62. Ondetti, M. A., Rubin, B., and Cushman, D. V. (1977) Design of specific inhibitors of angiotensin converting enzyme: new class of orally active anti-hypertensive agents. Science 196, 441-444.
63. Furukuwa, Y., Kishimoto, S., and Nishikawa, K. (1982) Hypotensive imidazole derivatives. US Patent 4,340,598 issued to Takeda Chemical industries, Ltd, Osaka, Japan.
64. Wong, P.C., Chiu, A.T., Price, W.A., et al. (1988) Nonpeptide angiotensin II receptor antagonists. I. Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl) imidazole-5-acetic acid, sodium salt (S-8307). J. Pharm. Exp. Therap. 247, 1-7.
65. Inagami, T., Murakami, K. (1977) Pure renin: isolation from hog kidney and characterization. J. Biol. Chem. 252, 2978-2983.
66. Corvol, P., Devaux, C., Ito, T., Sicard, P., Duclous, J., and Menard, J. (1977) Large scale purification of hog renin. Circ. Res. 41:612-622.
67. Lin, S-Y. andGoodfriend, T. (1970) Angiotensin receptors. Am. J. Physiology 218, 1319-1328.
68. Ruskin, A. (1956) Classics in Arterial Hypertension. Thomas, Springfield, IL, pp. ix-x.
69. Yanigisawa, M., Kurihara, H., Kimura, S., et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415.
70. Swales, J. D. (1994) Hypertension: the past, the present and the future. In Textbook of Hypertension (Swales, J. D., ed.) Blackwell Scientific Publishers, Oxford, pp. 1-7.